30 results
management differential hematology medications rheumatology tb tuberculosis activetb algorithm cardiology causes coccidioidomycosis hivaids idsa infections infectiousdiseases latenttb lung mycobacterium nephrology
Topical drug formulations, comparison and considerations #pharmacology #table #medications #comparison #drugs #treatment #pharmacotherapy #dermatology
considerations #pharmacology ... #table #medications ... #comparison #drugs ... #treatment #pharmacotherapy ... #dermatology
Shock and Vasoactive Drugs 1) Determine type and etiology of shock • Distributive: Sepsis, Anaphylaxis, Neurogenic
Pericardial tamponade, Pulmonary ... pharmacology ... inopressors #diagnosis ... #management #comparison ... #table
Drugs Used for the Treatment of COVID-19 Infection ** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
Drugs Used for the ... -19 Infection ... highlighted circle= clinical ... #COVID19 #Pharmacology ... #Table #Management
Hordeolum vs Chalazion Hordeolum (Stye): • Location: Most commonly found at or near an eyelash follicle •
Cause: Bacterial infection ... eyedrops, surgery #Clinical ... #Diagnosis #Management ... Stye #Chalazion #Comparison ... #Table
Approach to Eosinophilic Lung Diseases • Acute Eosinophilic Pneumonia (< 1 wk) - ~30yo, M; Recent
, CNS, skin • Infectious ... Fever, wheezing • Drug ... Lung #Diseases #pulmonary ... #differential #diagnosis ... #comparison #table
Invasive Aspergillus (IA) - Diagnosis and Management Aspergillus is ubiquitous in nature. Most invasive infections are caused
HIV/AIDS, CGD) Clinical ... presentations: • Pulmonary ... this morphology Treatment ... : • Drug of choice ... #Management #treatment
Tuberculosis Overview 10 million new M. tuberculosis infections/year Facultative intracellular rod-shaped bacteria Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
drug use • Silicosis ... characteristic features Clinical ... Tuberculosis Diagnosis ... Tuberculosis #TB #Diagnosis ... #Management #Treatment
TRALI vs TACO - Transfusion Reactions TRALI: • Epidemiology: 0.1% of transfused patientsl • Risk factors: Critical
Risk factors: Critical ... : 33% • Treatment ... , and CXR with pulmonary ... #diagnosis #comparison ... #table
Differentiating NBTE from Infective Endocarditis No pathognomonic signs/symptoms or echo features that are specific to NBTE, and
high index of clinical ... is required for diagnosis ... of intravenous drug ... #Endocarditis #comparison ... #table
Tuberculosis Overview 10 million new M. tuberculosis infections/year Facultative intracellular rod-shaped bacteria Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
drug use • Silicosis ... characteristic features Clinical ... Tuberculosis Diagnosis ... Tuberculosis #TB #Diagnosis ... #Management #Treatment
No results found for "infection pharmacology clinical diagnosis pulmonary comparison treatment table dermatology drugs"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #infection #pharmacology #clinical #diagnosis #pulmonary #comparison #treatment #table #dermatology #drugs